Skip to main content
Caplight Logo









Vitestro

Vitestro

Private
UtrechtHealthcare & Life Scienceshttps://vitestro.com/

Last Round

Series B

Mar 10, 2026

Total Funding Raised

$174.93M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vitestro is a medical robotics company that develops and manufactures autonomous blood drawing devices for hospitals and clinical laboratories.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Medical AI, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

autonomous blood drawrobotic phlebotomyblood collection robotvenipuncture automationmedical roboticsultrasound-guided roboticsAI-driven healthcaremedical devicephlebotomy automationlab automationhospital roboticsrobot nursemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vitestro Comparables

Compare Vitestro with similar companies based on industry and business-model similarity.

Vitestro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BHealthCare
91%
Veebot Systems Inc.
75%
AutonomUS Medical Technologies
63%

Vitestro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 10, 2026
Series A ExtensionApr 30, 2024
Series BMar 10, 2024
Series AMar 21, 2023

Key People

Founding team and executive leadership

Toon Overbeeke

CEO & Co-founder

Founding Team

Bert Wiggers

Chief Technology Officer

Executive Team

Jim Lelivelt

Chief Financial Officer

Executive Team

Vitestro Investors

Notable investors and investment history

Vitestro investors
InvestorRounds
Lifeblood CapitalSeries A Extension
InterVestSeries B
European Innovation Council FundSeries A Extension, Series B
Puma Venture CapitalSeries B
Invest-NLSeries A Extension, Series B
McPike Global Family OfficeSeries B
ROM Utrecht RegionSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Expected to grow from 100 to 140 employees this year.

  • Mar 10, 2026

    Aletta® device to launch in Netherlands in 2027, followed by Denmark and US.

Vitestro Filings

Explore SEC and related filing metadata, where available.

Vitestro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vitestro's valuation, stock price, and market status.

Is Vitestro a public or private company?

Vitestro is a private company.

What is the current stock price of Vitestro?

Vitestro is a private company with no public stock price. No recent secondary market data is available.

How much is Vitestro worth (valuation)?

Valuation information for Vitestro is not publicly available.

Can I buy Vitestro stock?

Vitestro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vitestro's last funding round?

Vitestro's most recent funding round was Series B on March 10, 2026.

Who are the main investors in Vitestro?

Key investors in Vitestro include Sonder Capital.

Will Vitestro IPO soon?

No public IPO plans have been announced for Vitestro.

How can I track Vitestro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vitestro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUtrecht
Employee Range119
Year Founded2017
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?